Covid: Researchers fear cancer advances delay due to pandemic
Scientists fear research has been pushed back due to the pandemic, a survey suggests.
Scientists fear research has been pushed back due to the pandemic, a survey suggests.
Unfortunately the website is temporarily unavailable. We are working to fix the issue and it should be back online shortly. We apologise for an inconvenience…
For decades, treatment for cancer was a blunt tool — everyone got the same, left to fight for their life chances against sometimes impossible odds.…
Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including when cancer has spread to a…
Prostate Cancer UK has today announced details of a £42 million screening trial, which aims to find the best way to screen men for prostate…
Patients with aggressive, incurable cancers saw their tumours stop growing after they began taking a twice-a-day tablet.
A new drug could offer a powerful way to sensitise tumours to immunotherapy, a new trial suggests.
Dr Stephen-John Sammut, a Clinician Scientist at The Institute of Cancer Research, London, and Honorary Consultant in Medical Oncology at The Royal Marsden NHS Foundation…
At the ICR, we are committed to improving the lives of cancer patients. Yet these discoveries take time and are only possible with continued support…
Combining two existing cancer drugs could offer promise for some children with an incurable childhood brain cancer, a new study suggests.
Scientists at The Institute of Cancer Research have helped discover and develop many targeted treatments that are enabling cancer patients to live longer and with…